Tsai Philip
Chief Technical Officer
Tsai Philip has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jul 27, 2026.
On the most recent filing, Tsai Philip is listed as Chief Technical Officer at Immunome Inc. Inside the rolling window, Tsai Philip reported 1 open-market purchase totaling $205K in IMNM and no open-market sales.
Companies traded
Other insiders at IMNM
Insider Buying
$205K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tsai Philip made?
Tsai Philip has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Tsai Philip trade?
Tsai Philip has filed SEC Form 4 disclosures for 1 company, including IMNM.
When was Tsai Philip's most recent SEC Form 4 filing?
Tsai Philip's most recent SEC Form 4 filing on Tracefour is dated Jul 27, 2026.
What is Tsai Philip's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tsai Philip is listed as Chief Technical Officer.
What is Tsai Philip's total buy and sell value in the current window?
Inside the rolling retention window, Tsai Philip bought $205K and sold $0 based on SEC Form 4 filings.
What was Tsai Philip's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 IMNM shares on 2025-12-19, worth $205K, per SEC Form 4 filings.